Promoting the use of quality‑assured generic and biosimilar medicines: WHO guideline on country pharmaceutical pricing policies: a plain language summary
21 June 2021
| Publication

Overview
Promoting the use of quality‑assured generic and biosimilar medicines creates access to lower‑priced equivalents or near equivalents of brand‑name products.
Number of pages
2
Reference numbers
ISBN: 978-92-4-002491-5